Dreny & Partners Advised Amer And Tropi 2 for Touristic Development Company On EGP 451 Million Securitization

Dreny & Partners advised Amer and Tropi 2 for Touristic Development Company on EGP 451 million securitization The leading, full-service independent law firm based in Egypt, Dreny & Partners advised Amer for Touristic Development Company and Tropi 2 for Touristic Development Company, both subsidiaries of Amer Group, on a securitization transaction amounting to EGP 451

... Continue Reading.

S&R Associates Advised IHH Healthcare Berhad On Its Acquisition Of Fortis Healthcare And Fortis Malar Hospitals

S&R Associates advised IHH Healthcare Berhad on its acquisition of Fortis Healthcare and Fortis Malar Hospitals The Leading law firm in India, S&R Associates represented IHH Healthcare Berhad (“IHH”), one of the world’s leading private healthcare groups, and its wholly-owned indirect subsidiaries, Northern TK Venture Pte. Ltd. (NTK) and Parkway Pantai Limited (PPL) (NTK as

... Continue Reading.

Herbert Smith Freehills Kramer Advised Lenders To The Jubail Buraydah Water Transmission Project

Herbert Smith Freehills Kramer advised lenders to the Jubail Buraydah water transmission project The Global Law firm, Herbert Smith Freehills Kramer has advised the lenders to the Jubail Buraydah water transmission project in Saudi Arabia. The project is the Kingdom’s second water transmission project and will significantly contribute to the National Water Strategy and Saudi

... Continue Reading.

Post-Limitation One-Time Settlement Proposal Doesn’t Extend Limitation Or Revive Time-Barred Debt

Post-Limitation One-Time Settlement Proposal Doesn’t Extend Limitation Or Revive Time-Barred Debt Introduction The National Company Law Tribunal (NCLT), Indore Bench, has clarified that a one-time settlement (OTS) proposal submitted after the expiry of the limitation period does not extend or renew the limitation period under Section 18 of the Limitation Act, 1963. A Bench comprising

... Continue Reading.

Shardul Amarchand Mangaldas Advised Jinyoung Electro-Mechanics Co. Ltd. On The Acquisition Of Jinyoung Sandhar Mechatronics Private Limited

Shardul Amarchand Mangaldas advised Jinyoung Electro-Mechanics Co. Ltd. on the acquisition of Jinyoung Sandhar Mechatronics Private Limited The leading law firm in India, Shardul Amarchand Mangaldas & Co. (SAM) advised Jinyoung Electro-Mechanics Co. Ltd. (JEM) on the acquisition of the remaining 50% stake in Jinyoung Sandhar Mechatronics Private Limited (JSM) from Sandhar Technologies Limited. With

... Continue Reading.

Another One Bites the Dust – NCLAT Ousts CCI’s Jurisdiction in Patent Matters

The NCLAT’s decision in Swapan Dey v. CCI marks the latest turn in the growing reluctance to let the CCI probe allegations of anti-competitive conduct stemming from the enforcement of patent rights. Yet, as Vasundra Koul points out, intellectual property and competition law are explicitly linked. Explaining the interplay between the Competition Act and the

... Continue Reading.

Shardul Amarchand Mangaldas Advised Oslo-listed Orkla ASA And Orkla India Limited On Its ₹16,670 Million Initial Public Offering

Shardul Amarchand Mangaldas advised Oslo-listed Orkla ASA and Orkla India Limited on its ₹16,670 million Initial Public Offering The leading law firm in India, Shardul Amarchand Mangaldas (SAM) advised Oslo-listed Orkla ASA and its Indian subsidiary, Orkla India Limited (formerly MTR Foods Private Limited), and its promoter selling shareholder, Orkla Asia Pacific Pte. Ltd., in

... Continue Reading.

Mask Off: Copyright, Deepfakes and the Commodification of the Self

As deepfakes become increasingly accessible and realistic, countries are scrambling to find the right legal response. In this post, Arnav Mathur examines Denmark’s proposed copyright-based approach and what India could learn from it for the ongoing debates on regulating AI-generated content. He argues that Denmark’s proposal to regulate deepfakes through copyright law is conceptually flawed

... Continue Reading.

Tissue culture cannot be separated from nursery activity: ITAT treats entire nursery receipts as agricultural income exempt u/s 10(1).

Tissue culture cannot be separated from nursery activity: ITAT treats entire nursery receipts as agricultural income exempt u/s 10(1). Modern agricultural practices such as tissue culture, when entwined with nursery operations, qualify for exemption under Section 10(1); the ruling reinforces. The Tribunal held that isolating laboratory stages from broader agricultural cycles is legally untenable. In

... Continue Reading.